TechnoPhage, SA - From science to innovative biopharmaceuticals
According to the indicator Gastão da Cunha Ferreira 2016, which studies the activity of international patenting of inventions with origin in Portugal, TechnoPhage is the 5th Portuguese company with more patents, and the 3rd in the pharmaceutical industry.
TechnoPhage, SA was awarded as a National SME Leader by IAPMEI – Public Agency for Competitiveness and Innovation. TechnoPhage, SA is very delighted to be publicly recognized by the performance of its business strategy and by its contribution to the national economy.
TechnoPhage SA is looking for a highly motivated and competitive candidate to apply for a FCT post-doc fellowship with knowledge in eukaryotic cell culture, flow cytometry, microscopy, molecular biology and protein production and purification. The candidate will integrate the antibody platform.    Qualifications: Ph.D. Eukaryotic cell culture (suspension cells, adherent cells, primary culture cells, differentiation of cells)…
TechnoPhage featured in CIP Magazine as one of the most innovative Portuguese companies with strong activity in intellectual property protection

2019 events

Phage Futures Europe
Brussels, Belgium, September 25-26, 2019